Pulmonary diseases associated with inflammatory bowel diseases

Area of Science:

• Pulmonology
• Gastroenterology
• Internal Medicine

Background:

• Extra-intestinal manifestations (EIMs) of inflammatory bowel diseases (IBD) are common, but pulmonary involvement is infrequent.
• Pulmonary complications in IBD patients encompass a diverse range of conditions.
• These lung issues can significantly impact patient health and require careful monitoring.

Purpose of the Study:

• To provide an overview of the spectrum of lung manifestations associated with inflammatory bowel diseases.
• To highlight the importance of recognizing these rare pulmonary conditions in IBD patients.
• To emphasize the need for prompt diagnosis and management of IBD-related lung diseases.

Main Methods:

• Literature review of reported cases and studies on pulmonary manifestations in IBD.
• Categorization of lung conditions based on their association with IBD (e.g., drug-induced, autoimmune, granulomatous).
• Analysis of the clinical presentation, diagnostic challenges, and treatment strategies for these conditions.

Main Results:

• A wide array of lung pathologies can occur in IBD patients, including airway diseases, drug-induced lung injury, granulomatous lung disease, autoimmune disorders, and thromboembolic events.
• While uncommon, these pulmonary manifestations can be severe and life-threatening.
• Early recognition and appropriate management are crucial for improving outcomes.

Conclusions:

• Pulmonary involvement in IBD, though rare, represents a significant clinical challenge.
• Awareness among healthcare providers and patients is essential for the timely identification and treatment of these conditions.
• Effective management of IBD-related lung diseases can prevent further health deterioration and alleviate patient symptoms.